Ampio Pharmaceuticals Inc Stock News
$0.241
+0.0155 (+6.89%)
At Close: May 07, 2024
Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis
09:15am, Tuesday, 06'th Apr 2021
ENGLEWOOD, Colo., April 6, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma
Ampio Pharmaceuticals is Building on its Progress in Tackling Osteoarthritis and COVID-19 Respiratory Issues
09:57am, Thursday, 01'st Apr 2021
Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, presented March
Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
09:15am, Monday, 29'th Mar 2021
ENGLEWOOD, Colo., March 29, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for pr
Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory Distress
09:15am, Tuesday, 16'th Mar 2021
ENGLEWOOD, Colo., March 16, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflam
Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
04:01pm, Wednesday, 10'th Mar 2021
ENGLEWOOD, Colo., March 10, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infla
Why Ampio Pharmaceuticals Stock Is Jumping Today
12:33pm, Thursday, 04'th Mar 2021
Investors liked what they heard in the company's Q4 update.
Ampio Pharmaceuticals' (AMPE) CEO Mike Macaluso on Q4 2020 Results - Earnings Call Transcript
11:04pm, Wednesday, 03'rd Mar 2021
Ampio Pharmaceuticals' (AMPE) CEO Mike Macaluso on Q4 2020 Results - Earnings Call Transcript
Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update
09:15am, Wednesday, 24'th Feb 2021
ENGLEWOOD, Colo., Feb. 24, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma
Ampio: Short-Term Triple-Digit Upside From Ampion's Progressing Phase 3 Drug Application
12:01am, Friday, 12'th Feb 2021
Ampio Pharmaceuticals, Inc. is a non-revenue producing biopharmaceutical company aiming to develop immunology-based therapies for inflammatory conditions. Ampio's pipeline consists of one late-stage t
Why Ampio Pharmaceuticals Stock Tanked Today
03:59pm, Tuesday, 29'th Dec 2020
Investors weren't comfortable with FDA feedback on the company's late-stage clinical trial.
Why MongoDB, Blink Charging, Ampio Pharmaceuticals, and Denali Therapeutics Stocks Tanked Today
03:33pm, Wednesday, 23'rd Dec 2020
2020 is almost over. Maybe it's time to cash in -- and cash out?
Implied Volatility Surging for Ampio Pharmaceuticals (AMPE) Stock Options
09:47am, Tuesday, 15'th Dec 2020
Investors need to pay close attention to Ampio Pharmaceuticals (AMPE) stock based on the movements in the options market lately.
Ampio Pharmaceuticals, Inc. (AMPE) CEO on Q3 2020 Earnings Results - Conference Call Transcript
03:04pm, Friday, 06'th Nov 2020
Ampio Pharmaceuticals, Inc. (AMPE) CEO on Q3 2020 Earnings Results - Conference Call Transcript
Brokerages Expect Ampio Pharmaceuticals, Inc. (NYSE:AMPE) to Announce -$0.02 Earnings Per Share
07:44am, Tuesday, 13'th Oct 2020
Analysts forecast that Ampio Pharmaceuticals, Inc. (NYSE:AMPE) will post ($0.02) earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates f
Hot Mover of the Day: Brickell Biotech, Inc. (NASDAQ:BBI), Ampio Pharmaceuticals, Inc. (AMEX:AMPE) - Stocks Equity
12:18pm, Saturday, 10'th Oct 2020
Brickell Biotech, Inc. (NASDAQ:BBI) with the stream of 0.96% also noticed, India Ampio Pharmaceuticals, Inc. (AMEX:AMPE) encountered a rapid change of -2.91% in the last hour of Friday’s trading ses
